The Effect of Breath Exercıse and Reıkı Applıcatıon
Launched by ASLIHAN ÖZTÜRK ÇETİN · Mar 24, 2025
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
The study was conducted with cancer patients receiving treatment in the outpatient chemotherapy unit of a university hospital between 1 December 2024 and 30 May 2024.The population of the study was 600 cancer patients receiving chemotherapy in the Outpatient Chemotherapy Unit of a university hospital. The sample consisted of patients who applied to the Medical Oncology Outpatient Clinic for treatment between 1 December 2023 and 30 May 2024, who accepted to participate in the study and met the inclusion criteria. Power analysis was performed to determine the sample size. The power of the stu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who volunteered to participate in the study, were diagnosed with cancer, had symptoms of nausea-vomiting and fatigue, were literate, could communicate, did not have a diagnosis of mental or psychiatric illness, were not hearing or visually impaired, were 18 years of age or older, and were not receiving antiemetic treatment.
- Exclusion Criteria:
- • Patients with any other disease related to the gastrointestinal system, any other disease or condition that would prevent them from performing the exercises to be performed for the study.
About Aslıhan öztürk çeti̇n
Aslıhan Öztürk Çetin is a dedicated clinical trial sponsor with a focus on advancing medical research and enhancing patient care through innovative therapeutic solutions. With a robust background in clinical research and a commitment to ethical standards, Çetin manages and oversees clinical trials that aim to evaluate the safety and efficacy of new treatments. Her expertise encompasses protocol development, regulatory compliance, and stakeholder engagement, ensuring that studies are conducted efficiently and with the utmost integrity. Through her leadership, Çetin fosters collaboration among research teams, healthcare professionals, and participants, driving the progress of scientific knowledge and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported